Skip to main content

and
  1. Article

    Open Access

    Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

    Immunochemotherapy is the first-line standard for extensive-stage small-cell lung cancer (ES-SCLC). Combining the regimen with anti-angiogenesis may improve efficacy. ETER701 was a multicenter, double-blind, r...

    Ying Cheng, Jianhua Chen, Wei Zhang, Chao **e, Qun Hu, Ningning Zhou in Nature Medicine (2024)

  2. Article

    Open Access

    Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

    Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of death worldwide. Due to latent liver disease, late diagnosis, and nonresponse to systemic treatments, surgical resection ...

    Qianwei Ye, Sunbin Ling, Shusen Zheng, **ao Xu in Molecular Cancer (2019)

  3. No Access

    Article

    The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer

    The aim was to investigate the function of fibroblast growth factor receptor 4 (FGFR4) in gastric cancer (GC) and explore the treatment value of agent targeted to FGFR4. Function assays in vitro and in vivo we...

    **g**g Li, Yanwei Ye, Min Wang, Lisha Lu, Chao Han, Yubing Zhou in Tumor Biology (2016)

  4. No Access

    Article

    Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer

    To clarify the role of fibroblast growth factor receptor 4 (FGFR4) in gastric cancer (GC) and explore the therapeutic value of BGJ398 targeted to FGFR4. We constructed lentivirus vectors to stably knockdown FG...

    Yanwei Ye, Dongbao Jiang, **g**g Li, Min Wang, Chao Han, **efu Zhang in Tumor Biology (2016)